Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cancer Treatment Reviews|May 19, 2015
Inter-patient variability in docetaxel pharmacokinetics: A reviewAnnemieke J M Nieuweboer, Ellen S de Morrée, Anne-Joy M de Graan, et al.British Journal of Clinical Pharmacology|April 5, 2014
Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifenRob ter Heine, Lisette Binkhorst, Anne Joy M de Graan, et al.Journal of Pharmaceutical and Biomedical Analysis|November 15, 2011
Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: a practical solution for non-specific bindingPeter de Bruijn, Anne-Joy M de Graan, Annemieke Nieuweboer, et al.Pharmacogenomics|August 13, 2015
Predicting paclitaxel-induced neutropenia using the DMET platformAnnemieke J M Nieuweboer, Marcel Smid, Anne-Joy M de Graan, et al.Pharmacogenetics and Genomics|January 18, 2013
Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycinLaure Elens, Annemieke J M Nieuweboer, Stephen J Clarke, et al.British Journal of Clinical Pharmacology|June 30, 2015
4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanesAnne-Joy M de Graan, Alex Sparreboom, Peter de Bruijn, et al.Journal of Pharmaceutical and Biomedical Analysis|October 8, 2010
Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometryWalter J Loos, Anne-Joy M de Graan, Peter de Bruijn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapyAnne-Joy M de Graan, Walter J Loos, Lena E Friberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platformAnne-Joy M de Graan, Laure Elens, Marcel Smid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatmentAnne-Joy M de Graan, Sebastiaan F Teunissen, Filip Y F L de Vos, et al.Pageof 2